EGFR and cancer: Although EGFR-mutated NSCLC typically is not associated with inflamed TME, characterized by low levels of CD8+ T cells and immune-suppressive cells, the numbers of Tregs and PD-L1 expression levels are increased in this cancer (Figure 2).